Resources for Researchers : Endocrinology
- Endocrinology Databases, Registries and Information
- Endocrinology Multicenter Clinical Research
- Endocrinology Basic Research Networks
- Endocrinology Reagents
- Endocrinology Services
- Endocrinology Standardization Programs
- Endocrinology Tissues, Cells, Animals
- Endocrinology Useful Tools
back to top
|
Beta Cell Biology Consortium (BCBC)
http://www.betacell.org/
The mission of the BCBC is to facilitate interdisciplinary approaches that will advance our understanding of pancreatic islet cell development, regenerative capacity and function. The long-term goal is to develop a cell-based therapy, or treatments leading to controlled beta-cell renewal, in order to restore normal insulin production to diabetic patients.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program or Dr. Sheryl Sato , DEM, Director, Neurobiology of Obesity and Developmental Biology Programs.
|
Central NIDDK Repository for Biosamples and Data
http://www.niddkrepository.org
On July 1, 2003, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) established Central NIDDK Repositories for biosamples and data collected in clinical studies. The purpose of the Central Repositories is to expand the usefulness of these studies by providing access to the biosamples and data to a wider research community beyond the end of the study.
For more information, contact Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases.
|
Diabetes Genome Anatomy Project (DGAP)
http://www.diabetesgenome.org/
The Diabetes Genome Anatomy Project (DGAP) represents a unique, multidimensional initiative whose goal is to unravel the interface between insulin action, insulin resistance and the genetics of type 2 diabetes. The overall goal of the project is to identify the sets of the genes involved in insulin action and the predisposition to type 2 diabetes, as well as the secondary changes in gene expression that occur in response to the metabolic abnormalities present in diabetes.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program.
|
National Gene Vector Laboratories (NGVL)
http://www.ngvl.org/
The National Gene Vector Laboratories (NGVL) are composed of an interactive group of academic production and pharm/tox laboratories whose primary goal is to provide eligible investigators with clinical grade vectors for phase I/II gene therapy clinical trials and to provide support for relevant pharmacology/toxicology studies leading up to clinical gene transfer protocols. If the application is approved, clinical grade material will be produced at no cost to the investigator.
For more information, contact Dr. Catherine McKeon, DEM, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases.
|
NIDDK Endocrine and Metabolic Diseases Information Service
http://www.endocrine.niddk.nih.gov
This public service provides information about endocrine and metabolic diseases in easy-to-understand language: online, in booklets and fact sheets, by email, and over the phone.
For more information, contact Ms. Kathy Kranzfelder, OCPL, Director, NIDDK Information Clearinghouses.
|
Nuclear Receptor Resource Project (NRR)
http://nrr.georgetown.edu/NRR/nrrhome.htm
The Nuclear Receptor Resource (NRR) Project is a collection of individual databases on members of the steroid and thyroid hormone receptor superfamily. Although the databases are located on different servers and are managed individually, they each form a node of the NRR. The NRR itself integrates the separate databases and allows an interactive forum for the dissemination of information about the superfamily.
For more information, contact Dr. Ronald Margolis, DEM, Senior Advisor, Molecular Endocrinology.
|
Nuclear Receptor Signaling Atlas (NURSA)
http://www.nursa.org/
Commensurate with this directive, NURSA's goals can be distilled into two broad aims: (i) to execute research strategies designed to rapidly and efficiently elucidate those facets of orphan nuclear receptor biology we deem most critical to its understanding; and (ii) to facilitate the generation of hypotheses, design of experiments and communication of results by scientists active in this field. We anticipate that this initiative will provide a valuable service to the nuclear receptor community by developing a web-accessible bioinformatics resource, in which current and emerging data will be organized into more accessible and "user-mineable" forms.
For more information, contact Dr. Ronald Margolis, DEM, Senior Advisor, Molecular Endocrinology.
|
back to top
|
Bypass Angioplasty Revascularization Investigation (BARI) 2 Diabetes
http://www.bari2d.org/
The NHLBI-led BARI-2D study aims to determine the best therapies for people with type 2 diabetes and moderately severe cardiovascular disease.
For more information, contact Dr. Teresa Jones, DEM, Director, Diabetes Complications Program
|
Diabetes Prevention Program (DPP)
http://www.bsc.gwu.edu/dpp/index.htmlvdoc
The DPP showed that lifestyle change or metformin delay the development of type 2 diabetes. The DPPOS is a long-term follow-up study of the DPP participants.
For more information, contact Dr. Sanford Garfield, DEM, Senior Advisor for Biometry and Behavioral Research Program.
|
Diabetes Prevention Program Outcomes Study (DPPOS)
http://www.bsc.gwu.edu/dpp/protocol.htmlvdoc
The Diabetes Prevention Program Outcomes Study is studying the long term effect of diet and exercise and the diabetes medication, metformin, on the delay of type 2 diabetes in participants of the Diabetes Prevention Program (DPP).
For more information, contact Dr. Sanford Garfield, DEM, Senior Advisor for Biometry and Behavioral Research Program.
|
back to top
|
Beta Cell Biology Consortium (BCBC)
http://www.betacell.org/
The mission of the BCBC is to facilitate interdisciplinary approaches that will advance our understanding of pancreatic islet cell development, regenerative capacity and function. The long-term goal is to develop a cell-based therapy, or treatments leading to controlled beta-cell renewal, in order to restore normal insulin production to diabetic patients.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program or Dr. Sheryl Sato , DEM, Director, Neurobiology of Obesity and Developmental Biology Programs.
|
Central NIDDK Repository for Biosamples and Data
http://www.niddkrepository.org
On July 1, 2003, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) established Central NIDDK Repositories for biosamples and data collected in clinical studies. The purpose of the Central Repositories is to expand the usefulness of these studies by providing access to the biosamples and data to a wider research community beyond the end of the study.
For more information, contact Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases.
|
Diabetes Genome Anatomy Project (DGAP)
http://www.diabetesgenome.org/
The Diabetes Genome Anatomy Project (DGAP) represents a unique, multidimensional initiative whose goal is to unravel the interface between insulin action, insulin resistance and the genetics of type 2 diabetes. The overall goal of the project is to identify the sets of the genes involved in insulin action and the predisposition to type 2 diabetes, as well as the secondary changes in gene expression that occur in response to the metabolic abnormalities present in diabetes.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program.
|
Network of Minority Research Investigators (NMRI)
http://nmri.niddk.nih.gov/
NMRI is a communication network of current and potential biomedical research investigators and technical personnel from traditionally under-served communities: African American, Hispanic American, American Indian, Alaskan Native, Native Hawaiian, and other Pacific Islanders. The major objective of the network is to encourage and facilitate participation of members of underrepresented racial and ethnic minority groups in the conduct of biomedical research in the fields of diabetes, endocrinology, metabolism, digestive diseases, nutrition, kidney, urologic and hematologic diseases. A second objective is to encourage and enhance the potential of the underrepresented minority investigators in choosing a biomedical research career in these fields. An important component of this network is promotion of two-way communications between network members and the NIDDK.
For more information, contact Ms. Winnie Martinez, Program Analyst, Office of Minority Health Research Coordination.
|
Nuclear Receptor Signaling Atlas (NURSA)
http://www.nursa.org/
Commensurate with this directive, NURSA's goals can be distilled into two broad aims: (i) to execute research strategies designed to rapidly and efficiently elucidate those facets of orphan nuclear receptor biology we deem most critical to its understanding; and (ii) to facilitate the generation of hypotheses, design of experiments and communication of results by scientists active in this field. We anticipate that this initiative will provide a valuable service to the nuclear receptor community by developing a web-accessible bioinformatics resource, in which current and emerging data will be organized into more accessible and "user-mineable" forms.
For more information, contact Dr. Ronald Margolis, DEM, Senior Advisor, Molecular Endocrinology.
|
back to top
|
Beta Cell Biology Consortium (BCBC)
http://www.betacell.org/
The mission of the BCBC is to facilitate interdisciplinary approaches that will advance our understanding of pancreatic islet cell development, regenerative capacity and function. The long-term goal is to develop a cell-based therapy, or treatments leading to controlled beta-cell renewal, in order to restore normal insulin production to diabetic patients.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program or Dr. Sheryl Sato , DEM, Director, Neurobiology of Obesity and Developmental Biology Programs.
|
Central NIDDK Repository for Biosamples and Data
http://www.niddkrepository.org
On July 1, 2003, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) established Central NIDDK Repositories for biosamples and data collected in clinical studies. The purpose of the Central Repositories is to expand the usefulness of these studies by providing access to the biosamples and data to a wider research community beyond the end of the study.
For more information, contact Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases.
|
National Gene Vector Laboratories (NGVL)
http://www.ngvl.org/
The National Gene Vector Laboratories (NGVL) are composed of an interactive group of academic production and pharm/tox laboratories whose primary goal is to provide eligible investigators with clinical grade vectors for phase I/II gene therapy clinical trials and to provide support for relevant pharmacology/toxicology studies leading up to clinical gene transfer protocols. If the application is approved, clinical grade material will be produced at no cost to the investigator.
For more information, contact Dr. Catherine McKeon, DEM, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases.
|
back to top
|
Beta Cell Biology Consortium (BCBC)
http://www.betacell.org/
The mission of the BCBC is to facilitate interdisciplinary approaches that will advance our understanding of pancreatic islet cell development, regenerative capacity and function. The long-term goal is to develop a cell-based therapy, or treatments leading to controlled beta-cell renewal, in order to restore normal insulin production to diabetic patients.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program or Dr. Sheryl Sato , DEM, Director, Neurobiology of Obesity and Developmental Biology Programs.
|
Center for Inherited Disease Research (CIDR)
http://www.cidr.jhmi.edu
A centralized facility established to provide genotyping and statistical genetics services for investigators seeking to identify genes that contribute to human disease. CIDR concentrates primarily on multifactorial hereditary disease although linage analysis of single gene disorders can also be accommodated.
For more information, contact Dr. Catherine McKeon, DEM, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases.
|
Central NIDDK Repository for Biosamples and Data
http://www.niddkrepository.org
On July 1, 2003, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) established Central NIDDK Repositories for biosamples and data collected in clinical studies. The purpose of the Central Repositories is to expand the usefulness of these studies by providing access to the biosamples and data to a wider research community beyond the end of the study.
For more information, contact Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases.
|
Rapid Access to Intervention Development (NIH RAID)
http://nihroadmap.nih.gov/raid/
NIH RAID provides a variety of contract services researchers need to bring promising potential therapeutics to trial.
|
back to top
|
There are none at this time. Please check back. |
back to top
|
Beta Cell Biology Consortium (BCBC)
http://www.betacell.org/
The mission of the BCBC is to facilitate interdisciplinary approaches that will advance our understanding of pancreatic islet cell development, regenerative capacity and function. The long-term goal is to develop a cell-based therapy, or treatments leading to controlled beta-cell renewal, in order to restore normal insulin production to diabetic patients.
For more information, contact Dr. Olivier Blondel, DEM, Director, Endocrine Systems Biology Program or Dr. Sheryl Sato , DEM, Director, Neurobiology of Obesity and Developmental Biology Programs.
|
Central NIDDK Repository for Biosamples and Data
http://www.niddkrepository.org
On July 1, 2003, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) established Central NIDDK Repositories for biosamples and data collected in clinical studies. The purpose of the Central Repositories is to expand the usefulness of these studies by providing access to the biosamples and data to a wider research community beyond the end of the study.
For more information, contact Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases.
|
Collaberative Projects in Proteomics or Metabolomics for Type 1 Diabetes
http://www.niddk.nih.gov/fund/diabetesspecialfunds/proteomics/
To encourage the application of proteomic and metabolomic technologies to study type 1 diabetes and its complications, the NIDDK is fostering collaborations between researchers studying type 1 diabetes and investigators with expertise in Proteomics and/or Metabolomics.
For more information, contact Dr. Salvatore Sechi, DEM, Director, Proteomic Program.
|
Mutant Mouse Regional Resource Centers (MMRRC)
http://www.mmrrc.org/
The goal of the MMRRC program is to enhance the availability of and help ensure the quality of genetically modified mice for biomedical research of human and animal biology and disease.
For more information, contact Dr. Kristin Abraham, DEM, Director, Cell Signaling and Diabetes Centers Program.
|
back to top
|
Body Mass Index Calculator
http://www.nhlbisupport.com/bmi/
BMI for adults can be calculated using only height and weight.
|
Page last updated: January 05, 2009